Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Amy Cha's publication output changed over time?
ScholarIQpublication output · 2000–2023
Output grew100% over the shown period — from 1 works in 2000 to 2 in 2023.
1
3
2
4
2
20002020202120222023
What are the most-cited papers on Amy Cha?
ScholarIQmost cited works
Health Insurance Coverage: Early Release of Estimates From the National Health Interview Survey, 2020
Cohen Robin, Emily Terlizzi, Amy Cha, Martinez Michael
2021353 Citations
Association Between Social Vulnerability and a County’s Risk for Becoming a COVID-19 Hotspot — United States, June 1–July 25, 2020
Sharoda Dasgupta, Virginia B. Bowen, Andrew J. Leidner, Kelly Fletcher, Trieste Musial, Charles E. Rose, Amy Cha, Gloria J. Kang, Emilio Dirlikov, Eric Pevzner, Dale A. Rose, Matthew D. Ritchey, Julie Villanueva, Celeste Philip, Leandris Liburd, Alexandra M. Oster
S183158886. 2020213 CitationsOPEN ACCESS
In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo.
Steven J. Chmura, M. Eileen Dolan, Amy Cha, Helena J. Mauceri, Donald Küfe, R.R. Weichselbaum
PubMed. 2000173 Citations
Health insurance coverage: Early release of estimates from the National Health Interview Survey, January–June 2021
Robin Cohen, Michael E. Martinez, Amy Cha, Emily Terlizzi
2021114 CitationsOPEN ACCESS
Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting
Lawrence F. Eichenfield, Stephen Stripling, Selwyn Fung, Amy Cha, Andryann O’Brien, Lawrence A. Schachner
S84493273. 2022105 CitationsOPEN ACCESS
Related on ScholarIQ
Pfizer (United States)
Institution
Health Insurance Coverage: Early Release of Estimates From the National Health Interview Survey, 2020
Paper
Association Between Social Vulnerability and a County’s Risk for Becoming a COVID-19 Hotspot — United States, June 1–July 25, 2020
Paper
In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo.
Paper
Health insurance coverage: Early release of estimates from the National Health Interview Survey, January–June 2021
Paper
Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting
Paper